The tip of the iceberg: Will GLP-1 receptor agonists unintentionally contribute to titanic cardiovascular events in certain individuals?

Curr Probl Cardiol. 2024 Aug;49(8):102676. doi: 10.1016/j.cpcardiol.2024.102676. Epub 2024 May 23.
No abstract available

Keywords: Cardiovascular risk; Pharmacology; Unhealthy lifestyle behaviors; Weight loss.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / epidemiology
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Glucagon-Like Peptide-1 Receptor* / agonists
  • Humans
  • Hypoglycemic Agents* / adverse effects
  • Hypoglycemic Agents* / therapeutic use

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor Agonists